D. Ilegbodu

Randomized Phase III Study of Trastuzumab, Paclitaxel, and Carboplatin Compared With Trastuzumab and Paclitaxel in Women With HER-2–Overexpressing Metastatic Breast Cancer

Nicholas J. Robert, Brian Leyland‐Jones, Lina Asmar et al. · Journal of Clinical Oncology · 2006 · 484 citations

Medicine, Oncology, Pharmacology +17

Comparison of Menopausal Symptoms During the First Year of Adjuvant Therapy With Either Exemestane or Tamoxifen in Early Breast Cancer: Report of a Tamoxifen Exemestane Adjuvant Multicenter Trial Substudy

Stephen E. Jones, James Cantrell, Svetislava J. Vukelja et al. · Journal of Clinical Oncology · 2007 · 81 citations

Medicine, Oncology, Pharmacotherapy +17

Phase II Trial of Capecitabine and Weekly Paclitaxel As First-Line Therapy for Metastatic Breast Cancer

Joanne L. Blum, Elizabeth Claire Dees, Aparna Chacko et al. · Journal of Clinical Oncology · 2006 · 62 citations

Medicine, Oncology, Pharmacology +17

A Randomized Phase III Trial of Combined Paclitaxel, Carboplatin, and Radiation Therapy Followed by Weekly Paclitaxel or Observation for Patients With Locally Advanced Inoperable Non–Small-Cell Lung Cancer

Dennis L. Carter, David Garfield, James W. Hathorn et al. · Clinical Lung Cancer · 2011 · 32 citations

Medicine, Oncology, Radiation Oncology +14

Randomized phase III study of trastuzumab, paclitaxel, and carboplatin versus trastuzumab and paclitaxel in women with HER-2 overexpressing metastatic breast cancer: An update including survival

N. J. Robert, Brian Leyland‐Jones, Lina Asmar et al. · Journal of Clinical Oncology · 2004 · 32 citations

Medicine, Oncology, Pharmacology +17